HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea · Delayed Price · Currency is KRW 6,530.00
+770.00 (13.37%)
At close: Oct 23, 2026
HLB bioStep Market Cap
HLB bioStep has a market cap or net worth of 112.35 billion as of October 23, 2026. It is the 26,239th most valuable company in the world and the 1,169th biggest in South Korea. Its market cap has decreased by 0.60% in one year.
Market Cap
112.35B
Enterprise Value
112.90B
Revenue
72.15B
Global Rank
Country Rank
#1,169 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 27, 2019, HLB bioStep's market cap has decreased from 254.44B to 112.35B, a decrease of -55.85%. That is a compound annual growth rate of -11.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 112.35B | -8.53% |
| Dec 30, 2025 | 122.82B | -30.37% |
| Dec 30, 2024 | 176.39B | -27.37% |
| Dec 28, 2023 | 242.88B | -25.95% |
| Dec 29, 2022 | 327.97B | 49.60% |
| Dec 30, 2021 | 219.23B | 14.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ingenia Therapeutics | 1.07T |
| Penetrium Bioscience | 315.98B |
| DreamCIS | 102.46B |
| P&K Skin Research Center | 49.10B |
| Kolmar BioTech | 34.84B |
| DT&CRO CO. | 27.42B |
| SLS BIO | 26.89B |
| C&R Research | 25.80B |